US Capital Global has provided or advised on over $1 billion in debt and equity financing for technology companies across the United States and abroad in the last 36 months.
More than anything, technology companies are associated with innovation and invention. Technology is an industry that generally comes with higher R&D overheads and that can require significant levels of capital expenditure. Structuring and securing the right business financing is therefore essential.
US Capital Global’s technology finance team understands the changing technology marketplace and the challenges owners and CFOs of technology companies face. The firm has deep experience in financing businesses across a wide range of technology sectors, such as enterprise and application software (including those leveraging blockchain and the Internet of Things), FinTech and MedTech, internet content and services, networking and communications technology, and electronics manufacturing and distribution.
“US Capital Global has a reputation for being an innovator in the technology financing space,” said Jeffrey Sweeney, Chairman and CEO at US Capital Global. “In the last 36 months, the firm has already provided or advised on over $1 billion in debt and equity financing for businesses serving the US technology industry. Our finance professionals understand the challenges and opportunities in the industry, and can design flexible solutions that fit the specific needs of your business.”
Click on the tombstones below for further details about these selected transactions.
Securities offered through US Capital Global Securities LLC (“USCGS”) the FINRA-member, SEC-registered broker-dealer division of US Capital Global. USCGS or its affiliates may provide advice to, be compensated by, may have other business relationships with, or may from time to time acquire, hold or sell a position in the securities of, the companies mentioned herein. Private debt and equity investments are not suitable for all investors, are generally illiquid, offer no guarantee of returns, and subject investors to possible loss of principal. Any offer or solicitation shall be made only pursuant to the confidential private placement memorandum. View USCGS’ Form CRS at www.uscapglobalsecurities.com/crs.html. 232103PR